Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis

AIMS: To investigate the efficacy and safety of lenvatinib and idarubicin‐loaded drug‐eluting beads transarterial chemoembolization (IDADEB‐TACE) in primary advanced hepatocellular carcinoma (HCC). METHODS: This retrospective study included patients with primary advanced HCC who received either lenv...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Wenzhe, Zhu, Bowen, Yue, Shufan, Zheng, Xinlin, Zou, Xinhua, Li, Fuliang, Qiao, Liangliang, Wu, Yanqin, Xue, Miao, Wang, Hongyu, Tang, Yiyang, Li, Jiaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844616/
https://www.ncbi.nlm.nih.gov/pubmed/35698292
http://dx.doi.org/10.1002/cam4.4937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844616/
https://www.ncbi.nlm.nih.gov/pubmed/35698292
http://dx.doi.org/10.1002/cam4.4937

Ejemplares similares